MedMira Inc MMIRF

Primary Symbol: V.MIR

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > HINDSIGHT BEEN BETTER OFF WITHOUT THE PLUS

<< Previous

Bullboard Posts

Next >>

Post by august202013on May 14, 2021 11:27am

779 Views

Post# 33203452

HINDSIGHT BEEN BETTER OFF WITHOUT THE PLUS

Would be anxiously waiting the next QUARTERLY RESULTS and cheering with price probably ranging between $0.75 - $0.95 Instead with ranging between $0.17 - $0.20. Or was Petey78 CORRECT all along. With each passing day not having the business will even to look for alternative to market into ASIA might be professional negligent as it weakens the COVID19 TEST KIT PLUS ability to generate the potential big BUGS. Not sure why STILL WAITING FOR USA FDA's APPROVAL. Have a great weekend.

<< Previous

Bullboard Posts

Next >>

Thesis Gold makes high-grade discovery at Ring Zone